Drug Database
Back to search

France· FR:66328396

ALDURAZYME 100 U/ml, solution à diluer pour perfusion

A laronidase product, registered in France by SANOFI (PAYS-BAS). The same ATC class is registered in 12 of our 19 countries.

ATC A16AB05

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedALDURAZYME 100 U/ml, solution à dilue…ATCA16AB05REGISTER NO.FR:66328396PACKS LISTED2CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ALDURAZYMEAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Laronidase is registered in 12 of 19 countries.

Countries holding a registration under ATC A16AB05 (laronidase), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 7 of them publish a price we can compare per daily dose
Search laronidase products by name

Laronidase · ATC A16AB05

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Manufacturer
SANOFI (PAYS-BAS)
Country
France (FR)
ATC code
A16AB05
ATC class
Laronidase
Defined daily dose
1 TSD, E
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

  • cip13
    3400930247037
    1 flacon(s) en verre de 5 ml
  • cip13
    3400956491711
    1 flacon(s) en verre de 5 ml ( abrogée le 12/09/2024)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for laronidase.

Graded by severity as the source publishes them — 2 minor. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check laronidase against other medicinesHow interaction checks work

Laronidase · interactions on record

2 records

  • 2 minor

Most severe, free to view

    Mechanism and what to do, in the interaction check
    Interaction register. Grades as the source publishes them.

    Same medicine, other countries

    Laronidase in 14 other countries

    What each register calls a product with the same active substance — salts and hydrates count as the same.

    All laronidase products

    Authorised across Europe · EMA

    The same active substance is authorised in 3 EEA countries. Names it is sold under:

    • Iceland · Aldurazyme
    • Liechtenstein · Aldurazyme
    • Norway · Aldurazyme

    Source: European Medicines Agency, Article 57 product data.

    Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

    For developers

    The same record over the API, and the raw payload
    GET /v1/drugs/dc775457-1764-4b68-8430-da091f6e2d95
GET /v1/drugs/dc775457-1764-4b68-8430-da091f6e2d95?format=fhir

    Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

    {
  "cis": "66328396",
  "date_amm": "2003-06-10",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/03/253",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution à diluer pour perfusion",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
    API referenceMCP serverPlans

    See everything about laronidase.

    This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

    Try it freeOpen in the console